Nassim Usman

Insider Reports History

Entity
Individual
Signature
/s/ Ruoyu Chen, as attorney-in-fact for Nassim Usman
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Nassim Usman:

Stock Role Class Num Shares Value Price $ Report Date Ownership
GYRE THERAPEUTICS, INC. Director Common Stock 1.64K $19.6K $12.00 Jun 28, 2024 Direct
GYRE THERAPEUTICS, INC. Director Common Stock 563 $6.76K $12.00 Jun 28, 2024 By The Usman Family Trust
GYRE THERAPEUTICS, INC. Director Common Stock 77 $924 $12.00 Jun 28, 2024 By Nassim Usman IRA
GYRE THERAPEUTICS, INC. Director Stock Option (Right to Buy) 278K Jun 28, 2024 Direct
CATALYST BIOSCIENCES, INC. Director Series Y Preferred Stock 0 Aug 31, 2023 By Nassim Usman IRA
CATALYST BIOSCIENCES, INC. Director Series Y Preferred Stock 0 Aug 31, 2023 By The Usman Family Trust
CATALYST BIOSCIENCES, INC. Director Series Y Preferred Stock 0 Aug 31, 2023 Direct

Insider Reports Filed by Nassim Usman

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GYRE GYRE THERAPEUTICS, INC. Jun 28, 2024 3 -$17.5K 4 Jul 1, 2024 Director
GYRE GYRE THERAPEUTICS, INC. May 1, 2024 5 -$144K 4 May 2, 2024 Director
GYRE GYRE THERAPEUTICS, INC. Apr 1, 2024 3 -$184K 4 Apr 3, 2024 Director
GYRE GYRE THERAPEUTICS, INC. Mar 15, 2024 3 -$207K 4 Mar 19, 2024 Director
CBIO GYRE THERAPEUTICS, INC. Oct 31, 2023 2 $0 4 Nov 1, 2023 Director
CBIO CATALYST BIOSCIENCES, INC. Aug 31, 2023 3 $0 4 Sep 1, 2023 President & CEO, Director
CBIO CATALYST BIOSCIENCES, INC. Aug 9, 2022 1 $1.53K 4 Aug 10, 2022 President & CEO, Director
CBIO CATALYST BIOSCIENCES, INC. Feb 9, 2022 1 $1.5K 4 Feb 16, 2022 President & CEO, Director
CBIO CATALYST BIOSCIENCES, INC. Aug 9, 2021 1 $3.14K 4 Aug 11, 2021 President & CEO, Director